This illustration depicts the nanolipogel, developed at Yale University with NSF support, administering its immunotherapy cargo. The light-blue spheres within the blood vessels and the cutaway sphere in the foreground, are the nanolipogels (NLGs). As the NLGs break down, they release IL-2 (the green specks), which helps recruit and activate a body's immune response (the purple, sphere-like cells). The tiny, bright blue spheres are the additional treatment, a cancer drug that inhibits TGF-beta (one of the cancer's defense chemicals).
Credit: Nicolle Rager Fuller, NSF
Download the high-resolution JPG version of the image. (1.4 MB)
Use your mouse to right-click (Mac users may need to Ctrl-click) the link above and choose the option that will save the file or target to your computer.
Yale University engineering professor Tarek Fahmy joined NSF to explain a novel, nanoscale, drug-delivery system that bundles powerful anti-cancer medicines into a single, treatment. The new approach solves several problems that hinder current drug delivery systems and has now proven effective in animal models.